Patent 8716450 was granted and assigned to AbbVie Inc. on May, 2014 by the United States Patent and Trademark Office.
The present invention relates to engineered multivalent and multispecific binding proteins, methods of making, and specifically to their uses in the prevention, diagnosis, and/or treatment of disease.